Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print ASU scientist: Study of first wave of swine flu requires revised public health strategies

ASU scientist: Study of first wave of swine flu requires revised public health strategies

June 30, 2009

Findings in New England Journal of Medicine point to younger populations

TEMPE, Ariz. - There is no way to know how the newest strain of the H1N1 influenza virus will behave in the future. But scientists, notably those working at the intersections of epidemiology, mathematics, modeling and statistics, are monitoring it closely to identify anomalies on its pattern of spread while evaluating ways of mitigating its impact.




"Public health officials have the ability to track confirmed cases and hospitalizations in real-time with modern data collection approaches and the aid of modeling as well as the ability to quickly identify new strains and track their evolution," says mathematical epidemiologist Gerardo Chowell-Puente, an assistant professor at Arizona State University's School of Human Evolution and Social Change in the College of Liberal Arts and Sciences.

Chowell-Puente is co-author of a new study of the A(H1N1) influenza pandemic strain circulating around the world. The study's findings reveal an age shift in the proportion of cases toward a younger population when compared with historical patterns of seasonal influenza in Mexico. The findings are published June 29 online in the New England Journal of Medicine. Other authors of "Reported severe respiratory disease and deaths concurrent with atypical A(H1N1) influenza circulation of swine origin in Mexico, 2009" include Stefano Bertozzi and Arantxa Colchero, Mexico's National Institute of Public Health; Hugo Lopez-Gatell, Celia Alpuche and Mauricio Hernandez, Mexico Ministry of Health; and Mark A. Miller, National Institutes of Health Fogarty International Center,

"The data show that the vast majority of cases of severe pneumonia and deaths occurred among those ages between 5 and 59, which is atypical when compared with the age pattern supported by seasonal flu," says Chowell-Puente. "If resources or vaccine supplies are limited, focusing prevention efforts on these age classes must be considered."

Specifically, according to the findings, 87 percent of the deaths and 71 percent of the cases of severe pneumonia occurred in persons aged 5-59, compared to an average 17 percent and 32 percent, respectively, for influenza seasons from 2006 through 2008. "These findings suggest relative protection for those persons exposed to H1N1 influenza viruses during childhood prior to the 1957 pandemic," Chowell-Puente says.

Chowell-Puente and other mathematicians and biostaticians attending a swine flu workshop at Arizona State University June 25-28, note that vaccines and anti-viral medications are in limited supply.

"Because achieving high vaccination rates before the fall is not feasible with current technologies, effective distribution of a limited vaccine and antiviral stockpiles will be crucial to mitigate a potential second pandemic wave. The seasonal influenza vaccination strategy focuses on the very young and the very old - the most vulnerable populations. This is not necessarily the case for pandemics as we showed in our study."

According to Chowell-Puente, the key to containing pandemic flu is closely tied in to the ability to quickly produce a good stockpile of vaccines and following a reactive distribution plan that targets the appropriate age cohorts of the population. The first wave of the current strain has not been particularly deadly, but subsequent waves may be more virulent, though it is too early to tell, he notes.

"For the 1918 ("Spanish flu") influenza pandemic, this was the pattern - first a mild wave, and then a severe one with higher case fatality rates," notes Chowell-Puente.

The features of the A(H1N1) epidemic, according to the findings, are "somewhat similar to past influenza pandemics in that circulation of a new influenza virus is associated with an unseasonal wave of disease affecting a younger population."

It is the hope of Chowell-Puente that making this data available will help politicians make science-based decisions on how to optimize the use of limited resources to manage this and future epidemics.

In addition to this latest research, Chowell-Puente also was a co-author on a recent study of the flu in Japan. "Here we looked at the public health strategies they used that essentially stopped the spread of the disease in its tracks," he says.

The researchers found that in Japan, more than 90 percent of the cases were in school-aged children and teens. Quick action was taken to contain the disease through school closures and other social distancing measures, such as avoiding use of public transportation and the use of face masks. In addition, Japan employed active surveillance at airports, using recently developed sensors to detect passengers with fevers for additional screening. The disease was contained within two-to-three weeks, with only about 500 cases and no fatalities. Findings from this study appeared in the June 4 issue of Eurosurveillance in an article titled "Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan."

Other authors on the Japanese study include: Hiroshi Nishiura, University of Utrecht, the Netherlands; Carlos Castillo-Chavez, Arizona State University; and Muntaser Safan, Mansoura University, Egypt.

Reducing the spread of the disease is key to preventing deaths, according to Chowell-Puente. "As transmissibility grows, timely implementation of control measures is key to reduce epidemic impact on the population."

Arizona State University



Related H1n1 Influenza Current Events and H1n1 Influenza News Articles H1n1 Influenza Current Events and H1n1 Influenza News RSS H1n1 Influenza Current Events and H1n1 Influenza News RSS
When should flu trigger a school shutdown?
As flu season approaches, parents around the country are starting to face school closures. But how bad should an influenza outbreak be for a school to shut down?

Initial Results Show Pregnant Women Mount Strong Immune Response To One Dose of 2009 H1N1 Flu Vaccine
Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.

Scientists discover influenza's Achilles heel: Antioxidants
As the nation copes with a shortage of vaccines for H1N1 influenza, a team of Alabama researchers have raised hopes that they have found an Achilles' heel for all strains of the flu-antioxidants.

Important new novel 2009 H1N1 flu advisory for cardiopulmonary transplantation
Each year 3-5 million people have severe cases and 250-500,000 die from complications of seasonal influenza world-wide. This year, the novel 2009 H1N1 (nH1N1) influenza, previously called swine flu, has reached pandemic status.

Paradigm shift needed to combat drug resistance
When people travel, bacteria and other infectious agents travel with them. As about a billion people cross international borders each year, many more billions of the bugs come along for the ride.

Fighting flu: Stricter hand hygiene in schools only a short-term measure
Increased hand hygiene in primary schools is only a short-term measure in preventing infections such as H1N1 from spreading.

Earlier flu viruses provided some immunity to current H1N1 influenza, study shows
University of California, Davis, researchers studying the 2009 H1N1 influenza virus, formerly referred to as "swine flu," have identified a group of immunologically important sites on the virus that are also present in seasonal flu viruses that have been circulating for years.

Flu surveillance boosts control, treatment options, says UAB travel-clinic chief
Because pandemics unfold in unpredictable ways, surveillance of travel-related illness is among the most powerful tools health officials and doctors can use to detect and respond to new pathogens like the novel H1N1 influenza, says the physician who heads the University of Alabama at Birmingham (UAB) Travelers' Clinic.

H1N1 simulation modeling shows rapid vaccine rollout effective in reducing infection rates
Early action, especially rapid rollout of vaccines, is extremely effective in reducing the attack rate of the H1N1 influenza virus, according to a simulation model of a pandemic outbreak reported in a new study in CMAJ.

NIH launches 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women
The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in pregnant women launched yesterday, and a trial to conduct the same test in HIV-infected children and youth will begin next week.
More H1n1 Influenza Current Events and H1n1 Influenza News Articles
Final Epidemic

Final Epidemic
by Earl Merkel (Author)

Causes: Unknown

At first, they thought it was a cold or maybe the flu. Then people started dropping where they stood.

Symptoms: Unthinkable

It could kill in hours. There was no known cure, no vaccine, and the only antidote could kill millions.

Diagnosis: Unstoppable.

New York, Chicago and Florida are quarantined. International travel is halted. A Japanese doomsday cult commits mass suicide, its final mission accomplished. Physician Carol Mayer was the first person to alert the Center for Disease Control, but now, as the epidemic grows, she has one last hope for finding a vaccine. His name is Beck Casey, a former CIA expert on biological warfare. And the best potential sources for stopping this plague are the worst enemies from his...

Warning Swine Flu Test Subject Keep Back Sign Logo Men's Tee Short Sleeve Size XL White

Warning Swine Flu Test Subject Keep Back Sign Logo Men's Tee Short Sleeve Size XL White
by 99 Volts



H1N1 and Swine Influenza (Flu) Protection Kit w/ N95 Masks - Meets CDC Guidelines for H1N1 and Swine Flu

H1N1 and Swine Influenza (Flu) Protection Kit w/ N95 Masks - Meets CDC Guidelines for H1N1 and Swine Flu
by JIB EDP

Protect against all Influenza's (Flu) Help protect yourself and your family with this Flu Defense Kit. The masks contained in the kit are N95 rated and meet guidelines set forth by the CDC and the Department of Health and Human Services for influenza (flu) protection. In addition to this kit, you MUST: Stay informed. - Influenza is thought to spread mainly person-to-person through coughing or sneezing of infected people. - Take everyday actions to stay healthy. -Cover your nose and mouth with a tissue when you cough or sneeze. Throw the tissue in the trash after you use it. - Wash your hands often with soap and water, especially after you cough or sneeze. Alcohol-based hands cleaners are also effective. - Avoid touching your eyes, nose or mouth. Germs spread that way. - Stay home...

CleenFreek SportsHygiene 30-Count Equipment and Surface Wipes

CleenFreek SportsHygiene 30-Count Equipment and Surface Wipes
by CleenFreek

CleenFreek wipes address the growing concern among doctors, coaches, athletic trainers, and parents over Staph, and Antibiotic Resistant Staph Infections. Methicillin-resistant staphylococcus aureus (CAMRSA) is affecting athletes at alarming rates. Health clubs, locker rooms and fields of play have become havens for this bacteria. CleenFreek wipes provides patented FDA and EPA registered germ kill technology with first to market (MRSA) kill claims, helping insure prevention and protection for athletes at every level on and off the field.

60 Minutes - H1N1 (October 18, 2009)

60 Minutes - H1N1 (October 18, 2009)

Airdate 10/18/09  The H1N1 virus is already setting infection records in this country, and while most people who get this flu can handle it, in some cases, H1N1 can be deadly. Scott Pelley follows the case of 15-year-old Luke Duvall, a high school athlete in intensive care in Little Rock, Arkansas. With staphylococcal pneumonia on top of the H1N1, Luke is on a respirator and fighting for his life.

This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.

GIANT Microbes Plush Doll Swine Flu (Influenza A virus H1N1)

GIANT Microbes Plush Doll Swine Flu (Influenza A virus H1N1)
by Giant Microbes

This little piggy had swine flu, this little piggy had none. Giant Microbes are stuffed 'animals' that look like tiny microbesonly a million times actual size! Each 5-to-7 inch doll is accompanied by an image of the real microbe it represents, as well as information about the microbe. They make great learning tools for parents and educators, as well as amusing gifts for anyone with a sense of humor!

Encyclopedia of Swine Flu (H1N1) and Influenza, 2009: An encK Resource for Parents, Patients & Professionals

Encyclopedia of Swine Flu (H1N1) and Influenza, 2009: An encK Resource for Parents, Patients & Professionals
by NewsRx (Publisher)

Encyclopedia of Swine Flu (H1N1) and Influenza, 2009: An encyK Resource for Parents, Patients & Professionals is a comprehensive compendium of reports on the epidemiology, pathology and incidence of the H1N1 strain of influenza. It contains both up-to-date information on the 2009 outbreak and pandemic, as well as historical perspective on the genetic evolution of the H1N1 mutation and how it may combine with other flu variants to produce a killer virus. Included are reports from the Centers for Disease Control and the World Health Organization, and these organizations' consumer advisories for step to protect against infection.

Avian Influenza (NCME Video 853)

Avian Influenza (NCME Video 853)
Also With: Network For Continuing Medical Education (Primary Contributor), Alan M. Sanders (Primary Contributor)

Global concern about the potential for pandemic avian influenza is rooted in the pathogenicity of avian influenza virus strains in humans and the lack of immunity to these highly mutable viruses in the general population. Avian influenza A (H5N1) re-emerged in 2003 with greater virulence and a wider host range than that seen following its 1997 debut. Although transmission of avian influenza A (H5N1) from animals to humans remains inefficient at this time, mutation or genetic reassortment with human influenza virus strains could trigger an influenza pandemic facilitated by the mobility of modern society and the lack of an effective vaccine. Dr. Alan Sanders provides timely, practical advice on how to improve clinical awareness and implement strategies for diagnosing, treating, and...

Silverclene24 Flu Virus Disinfectant, Gallon Bottle

Silverclene24 Flu Virus Disinfectant, Gallon Bottle
by Agion

SilverClene24TM is a liquid disinfectant and virucide that harnesses the natural protection of silver. SilverClene24 can be used to clean any hard, non porous surface and keep it clean and germ-free for 24 hours. It is even effective against such troublesome microbes as MRSA, VRE, HIV, Influenza, Rhinovirus, Poliovirus, and Trichophyton mentagrophytes (athletes foot fungus). It is EPA registered and safe when used as directed. Non-returnable, all sales final.

2009 Essential Guide to the Swine Flu (H1N1 Influenza A) Pandemic - Vital Plans, Scientific Reports, and Checklists to Help You and Your Organization Prepare for an Influenza Pandemic (Two CD-ROM Set)

2009 Essential Guide to the Swine Flu (H1N1 Influenza A) Pandemic - Vital Plans, Scientific Reports, and Checklists to Help You and Your Organization Prepare for an Influenza Pandemic (Two CD-ROM Set)
by U.S. Government (Author)

This up-to-date and comprehensive electronic book on two CD-ROM discs provides the best collection available anywhere of official Federal government documents on the vital subject of the new strain of influenza virus discovered in April 2009, the swine flu or H1N1 Influenza A (called Swine-Origin Influenza Virus, S-OIV). In response to an intensifying outbreak in the United States and internationally caused by a new influenza virus of swine origin, the World Health Organization raised the worldwide pandemic alert level to Phase 5 on April 29, 2009. This thoroughly researched collection presents vital information from many authoritative sources: Food and Drug Administration (FDA), Centers for Disease Control (CDC), National Institutes of Health (NIH), NIAID, Health and Human Services...

© 2009 BrightSurf.com